RAM
ARKG icon

Redmond Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Redmond Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,000
Closed -$201K – 163
2018
Q3 		$201K Buy
+6,000
New +$190K 0.08% 167

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
Arlington Capital Management Arlington Heights, Illinois $161M AUM 38.38% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Financial Engines Advisors
Financial Engines Advisors Santa Clara, California $56.3B AUM 17.83% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $4.23B AUM 29.95% 1-Year Est. Return

Redmond Asset Management's ARKG Position: Q4 2018 in Review

Redmond Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2018, closing a stake of 6,000 shares — an estimated $201K sold.

Redmond Asset Management first reported a position in ARKG in Q3 2018 and held it in 1 quarter. The position peaked at $201K in Q3 2018. 59 funds tracked by Wall St. Rank hold ARKG as of Q4 2018.

  • Redmond Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2018 after selling out during the quarter.
  • Redmond Asset Management sold 6,000 ARK Genomic Revolution ETF shares in Q4 2018, an estimated $201K.
  • Redmond Asset Management first reported a position in ARK Genomic Revolution ETF in Q3 2018 and held it in 1 quarter.
  • Redmond Asset Management's ARK Genomic Revolution ETF position peaked at $201K in Q3 2018.
  • 59 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2018.

Based on Redmond Asset Management's 13F filing for Q4 2018, filed 6 Feb 2019.